NCT04047121View on ClinicalTrials.gov

A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients

CompletedOBSERVATIONAL
Enrollment

1,349

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
Rheumatoid Arthritis
Trial Locations (1)

19426

Pfizer, Collegeville

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04047121 - A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter